Cite

    G. Haugeberg et al.. “AB1330 If remission and low disease activity is the treatment goal in rheumatoid arthritis, how far are we from this goal in patients currently treated with biologics in ordinary clinical practice? Data from the norwegian biorheuma project.” Annals of the rheumatic diseases, vol. 71, n.d., p. 713. http://access.bl.uk/ark:/81055/vdc_100137781007.0x00005f